Our global pharmaceutical client had an immunotherapy in early-stage clinical development. It engaged Prescient to
Prescient developed a five-year forecast of potential cellular therapy patients to guide our client’s treatment center qualification strategy.
Market Opportunity Mapping: Identifying Opportunities for a First-in-Class Product in a Crowded Space
Our client, a global pharmaceutical company, needed to identify opportunities in the EU5 countries for